UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

Annals of oncology, 2013-06, Vol.24 (6), p.1548-1552

2013

Volltextzugriff (PDF)

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Annals of oncology, 2011-11, Vol.22 (11), p.2466-2470

2011

Volltextzugriff (PDF)

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii743-viii744

2018

Volltextzugriff (PDF)

An unusual development following anti-tuberculous treatment: Obstructive inflammatory granuloma

Revue des maladies respiratoires, 2019-04, Vol.36 (4), p.553

2019

Volltextzugriff (PDF)

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Annals of oncology, 2017-05, Vol.28 (5), p.1078-1083

2017

Volltextzugriff (PDF)

Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S

Cancer genetics, 2021-08, Vol.256-257, p.158-161

2021

Volltextzugriff (PDF)

IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel in 1L advanced squamous NSCLC

Annals of oncology, 2018-10, Vol.29, p.viii750-viii751

2018

Volltextzugriff (PDF)

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)

BMC cancer, 2015-11, Vol.15 (858), p.857-857, Article 857

2015

Volltextzugriff (PDF)

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.415-419

2014

Volltextzugriff (PDF)

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

Lung cancer (Amsterdam, Netherlands), 2012-07, Vol.77 (1), p.97-103

2012

Volltextzugriff (PDF)

Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]

Lung cancer (Amsterdam, Netherlands), 2015-02, Vol.87 (2), p.210-210

2015

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

Choice, coercion, and/or muddling through: Older adults’ experiences in seeking psychological treatment

Social science & medicine (1982), 2020-06, Vol.255, p.113011-8, Article 113011

2020

Volltextzugriff (PDF)

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study

Annals of oncology, 2006-09, Vol.17 (9), p.1412-1417

2006

Volltextzugriff (PDF)

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

Annals of oncology, 2015-05, Vol.26 (5), p.908-914

2015

Volltextzugriff (PDF)

Impact of a comprehensive geriatric assessment on management strategies in elderly patients with advanced no small cell lung cancer (NSCLC): A polled analysis of two phase 2 prospective study of the GFPC group

Journal of geriatric oncology, 2014-10, Vol.5, p.S17-S18

2014

Volltextzugriff (PDF)

1262MO Impact of a minimal versus CT-scan-based follow-up on patient-reported outcomes for completely resected non-small cell lung cancer (NSCLC) in phase III IFCT-0302 trial

Annals of oncology, 2023-10, Vol.34, p.S732-S732

2023

Volltextzugriff (PDF)

PO-1015: SBRT after CT-RT for stage III unresectable NSCLC with peripheral primary tumor (GFPC 01-14 study)

Radiotherapy and oncology, 2020-11, Vol.152, p.S541-S542

2020

Volltextzugriff (PDF)

Comparison of racecadotril and loperamide in children with acute diarrhoea

Alimentary pharmacology & therapeutics, 1999-12, Vol.13 (s6), p.27-32

1999

Volltextzugriff (PDF)

Randomized multicentric phase II study of carboplatin /gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie)

Lung cancer (Amsterdam, Netherlands), 2006, Vol.51 (1), p.105-114

2006

Volltextzugriff (PDF)

1235TiP Perioperative pembrolizumab + platinum-based chemotherapy for resectable locally advanced non-small cell lung cancer: The phase III KEYNOTE-671 study

Annals of oncology, 2020-09, Vol.31, p.S801-S802

2020

Volltextzugriff (PDF)

Racecadotril demonstrates intestinal antisecretory activity in vivo

Alimentary pharmacology & therapeutics, 1999-12, Vol.13 (s6), p.3-7

1999

Volltextzugriff (PDF)

Une séquelle peu fréquente après traitement antituberculeux : l’obstruction granulomateuse inflammatoire

Revue des maladies respiratoires, 2019-04, Vol.36 (4), p.553-556

2019

Volltextzugriff (PDF)

Racecadotril versus placebo in the treatment of acute diarrhoea in adults

Alimentary pharmacology & therapeutics, 1999-12, Vol.13 (s6), p.15-19

1999

Volltextzugriff (PDF)

1306P Platin pemetrexed with or without bevacizumab with upfront versus “at progression” brain radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis: A randomized phase III trial (Metal2 trial)

Annals of oncology, 2020-09, Vol.31, p.S845-S845

2020

Volltextzugriff (PDF)

1 – 25 von 742

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(621)
Mit Volltextzugriff
(538)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)

An unusual development following anti-tuberculous treatment: Obstructive inflammatory granuloma

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S

IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel in 1L advanced squamous NSCLC

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Choice, coercion, and/or muddling through: Older adults’ experiences in seeking psychological treatment

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

Impact of a comprehensive geriatric assessment on management strategies in elderly patients with advanced no small cell lung cancer (NSCLC): A polled analysis of two phase 2 prospective study of the GFPC group

1262MO Impact of a minimal versus CT-scan-based follow-up on patient-reported outcomes for completely resected non-small cell lung cancer (NSCLC) in phase III IFCT-0302 trial

PO-1015: SBRT after CT-RT for stage III unresectable NSCLC with peripheral primary tumor (GFPC 01-14 study)

Comparison of racecadotril and loperamide in children with acute diarrhoea

Randomized multicentric phase II study of carboplatin /gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie)

1235TiP Perioperative pembrolizumab + platinum-based chemotherapy for resectable locally advanced non-small cell lung cancer: The phase III KEYNOTE-671 study

Racecadotril demonstrates intestinal antisecretory activity in vivo

Une séquelle peu fréquente après traitement antituberculeux : l’obstruction granulomateuse inflammatoire

Racecadotril versus placebo in the treatment of acute diarrhoea in adults

1306P Platin pemetrexed with or without bevacizumab with upfront versus “at progression” brain radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis: A randomized phase III trial (Metal2 trial)

Suchergebnisse filtern